Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment

clinical trial

Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT04302402

P6099clinical trial phasephase II clinical trialQ42824440
P17countryIndiaQ668
P582end time2021-03-01
P4135maximum age65
P2899minimum age18
P1132number of participants132
P4844research interventionrifaximinQ416073
P859sponsorSanjay Gandhi Post Graduate Institute of Medical SciencesQ7418428
P580start time2020-03-01
P8363study typeinterventional studyQ78089383
P1476titleMulti-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment: A Randomized Controlled Trial

Search more.